Scotland is world’s first country to greenlight Tagrisso for NSCLCScotland has given the green light to AstraZeneca’s Tagrisso for restricted use to treat adult patients with non-small Share XScotland is world’s first country to greenlight Tagrisso for NSCLChttps://pharmaphorum.com/news/scotland-is-worlds-first-country-to-greenlight-tagrisso-for-nsclc/
AstraZeneca cancer drugs approved in JapanAstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months Share XAstraZeneca cancer drugs approved in Japanhttps://pharmaphorum.com/r-d/astrazenecas-cancer-drugs-approved-japan/
AstraZeneca and Lilly’s Alzheimer’s drug fails trialThe battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase Share XAstraZeneca and Lilly’s Alzheimer’s drug fails trialhttps://pharmaphorum.com/news/astrazeneca-lillys-alzheimers-drug/
Could digital technology revolutionise pharma in 2018?This year’s eyeforpharma conference in Barcelona outlined how 2018 could be a turning point for the industry. As Share XCould digital technology revolutionise pharma in 2018?https://pharmaphorum.com/views-and-analysis/digital-technology-revolutionise-pharma-2018/
